NCT07764562

Brief Summary

Ultrasound-guided internal jugular vein (IJV) catheterization is widely used in critically ill patients. Despite ultrasound guidance, difficult catheterization and first-pass failure remain clinically important and may increase the risk of mechanical complications. Pre-procedural characteristics of the IJV, its anatomical relationship with the common carotid artery (CCA), head rotation, and operator experience may influence procedural success. The ROTATE-ICU study is a prospective observational cohort study designed to investigate pre-procedural ultrasound and clinical predictors of difficult IJV catheterization in critically ill adults. Consecutive adult intensive care unit patients undergoing ultrasound-guided IJV central venous catheterization will undergo standardized pre-procedural ultrasound assessment. IJV anterior-posterior diameter, skin-to-vessel depth, IJV position relative to the CCA, head rotation angle, operator experience, and relevant clinical and procedural characteristics will be recorded. The primary objective is to develop and internally validate a clinical prediction model for cannulation difficulty and first-pass cannulation outcome. Secondary objectives include evaluating the relationship between head rotation and IJV morphology and describing the association between complete IJV collapse and procedural outcomes. The planned enrollment is 150 participants.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Jun 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Jun 2026Sep 2026

Study Start

First participant enrolled

June 26, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 10, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2026

Last Updated

August 14, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

August 10, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

Internal jugular vein; Central venous catheterization; Ultrasound guidance; First-pass success; Critical care; Prediction model.

Outcome Measures

Primary Outcomes (1)

  • First-Pass Internal Jugular Vein Cannulation Success

    Successful advancement of the guidewire following the first skin puncture without needle redirection or an additional skin puncture.

    During the catheterization procedure, from initial skin puncture until successful guidewire placement, approximately 30 minutes

Secondary Outcomes (6)

  • Difficult Internal Jugular Vein Catheterization

    During the catheterization procedure, approximately 30 minutes

  • Total number of skin punctures required to achieve successful catheterization

    During the catheterization procedure

  • Arterial Puncture

    During catheterization and immediately after the procedure

  • Hematoma

    During catheterization and immediately after the procedure

  • Catheter Malposition

    Immediately following catheterization

  • +1 more secondary outcomes

Other Outcomes (3)

  • Association Between Head Rotation Angle and IJV AP Diameter

    Immediately before catheterization.

  • Association Between Head Rotation and IJV-CCA Positional Relationship

    Immediately before catheterization.

  • Complete IJV Collapse

    Immediately before and during catheterization.

Study Arms (1)

Critically Ill Patients Undergoing IJV Catheterization

Adult intensive care unit patients undergoing clinically indicated ultrasound-guided internal jugular vein central venous catheterization. Participants will undergo standardized pre-procedural ultrasound assessment and prospective recording of procedural outcomes. No study-specific therapeutic intervention will be assigned.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill adults requiring ultrasound-guided IJV CVC

You may qualify if:

  • Age ≥18 years. Admission to the intensive care unit. Clinical indication for central venous catheterization. Planned internal jugular vein access. Planned ultrasound-guided catheterization. Written informed consent obtained from the participant or legally authorized representative, where required.

You may not qualify if:

  • Active cardiopulmonary resuscitation at the time of catheterization. Neck anatomical abnormality preventing standard IJV assessment or catheterization.
  • Neck hematoma. Active local soft-tissue infection at the proposed access site. Planned vascular access through a site other than the internal jugular vein. Planned catheterization without ultrasound guidance. Refusal or inability to obtain required informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antalya training and research hospital health sciences university

Antalya, 07059, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Zawadka M, Czarnik T, Gawda R, Milobedzka M, Trzebicka J, Krolicki T, Owczuk R, Czuczwar M, Bialka S, Gola W, Aszkielowicz A, Latos M, Wludarczyk A, Szczeklik W, Putowski Z. Central venous cannulation in critically ill patients: guidelines of the Polish Society of Anaesthesiology and Intensive Therapy. Anaesthesiol Intensive Ther. 2026 May 21;58(1):84-105. doi: 10.5114/ait/220388.

    PMID: 42246225BACKGROUND

Study Officials

  • Şule Asri̇

    Antalya Health Sciences University

    PRINCIPAL INVESTIGATOR
  • Asri, M.D

    Antalya Health Sciences University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Şule Asri̇, M.D

CONTACT

Dilara Tüfek Öztan, M.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
15 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 14, 2026

Study Start

June 26, 2026

Primary Completion (Estimated)

September 26, 2026

Study Completion (Estimated)

September 26, 2026

Last Updated

August 14, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations